This research proposes the Kavya-Manoharan Unit Exponentiated Half Logistic (KM-UEHL) distribution as a novel tool for epidemiological modeling of COVID-19 data. Specifically designed to analyze data constrained to the unit interval, the KM-UEHL distribution builds upon the unit exponentiated half logistic model, making it suitable for various data from COVID-19. The paper emphasizes the KM-UEHL distribution's adaptability by examining its density and hazard rate functions. Its effectiveness is demonstrated in handling the diverse nature of COVID-19 data through these functions. Key characteristics like moments, quantile functions, stress-strength reliability, and entropy measures are also comprehensively investigated. Furthermore, the KM-UEHL distribution is employed for forecasting future COVID-19 data under a progressive Type-II censoring scheme, which acknowledges the time-dependent nature of data collection during outbreaks. The paper presents various methods for constructing prediction intervals for future-order statistics, including maximum likelihood estimation, Bayesian inference (both point and interval estimates), and upper-order statistics approaches. The Metropolis-Hastings and Gibbs sampling procedures are combined to create the Markov chain Monte Carlo simulations because it is mathematically difficult to acquire closed-form solutions for the posterior density function in the Bayesian framework. The theoretical developments are validated with numerical simulations, and the practical applicability of the KM-UEHL distribution is showcased using real-world COVID-19 datasets.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11417215 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2024.e36774 | DOI Listing |
Sci Rep
January 2025
Bioinformatics Centre, Savitribai Phule Pune University, Pune, Maharashtra, 411007, India.
COVID-19 has proved to be a global health crisis during the pandemic, and the emerging JN.1 variant is a potential threat. Therefore, finding alternative antivirals is of utmost priority.
View Article and Find Full Text PDFBMC Prim Care
January 2025
Department of Family Medicine, Jagiellonian University Medical College, Kraków, 31-061, Poland.
Background: The COVID-19 pandemic has caused psychological distress to the population and healthcare workers. Physicians' well-being is essential and contributes significantly to overall health. This study aimed to assess the strain on Polish general practitioners from the effects of the COVID-19 pandemic and to ascertain the potential predictors of their distress.
View Article and Find Full Text PDFBMJ Open
January 2025
Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, UK.
Objectives: To evaluate the effectiveness of localised Tier 3 restrictions, implemented in England in December 2020, on reducing COVID-19 hospitalisations compared with less stringent Tier 2 measures and the variations by neighbourhood deprivation and the prevalence of Alpha (B.1.1.
View Article and Find Full Text PDFTransplant Proc
January 2025
Gastroenterolgy and Hepatology Department, Group of Clinical and Translational Research in Liver Diseases, Research Institution Valdecilla (IDIVAL), University Hospital Marqués de Valdecilla, Santander, Spain. Electronic address:
Background: The Omicron variant of SARS-CoV-2 emerged as a new variant of concern, characterized by high transmissibility and lower severity compared with previous variants, and became the majority variant in the sixth wave in Spain. This study aims to assess the impact of SARS-CoV-2 infection on liver transplant recipients (LTRs) during 2023 in the population of Cantabria.
Methods: The study included 295 LTRs undergoing follow-up at the Liver Transplant Unit of the Marqués de Valdecilla University Hospital.
Lancet Public Health
January 2025
US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Background: Rapid, accessible, and accurate testing was paramount to an effective US COVID-19 response. Federal partners supported SARS-CoV-2 testing scale-up through an interagency-coordinated approach that focused on expanding supply chains, research and development, validation, and improving patient access. We aimed to provide an overview of the federal efforts to scale up the testing response and study the impact of scale-up.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!